| IVGSX | RMFEX | IVGSX / RMFEX | |
| Total Expense Ratio | 0.89 | 0.62 | 144% |
| Annual Report Gross Expense Ratio | 0.89 | 0.62 | 144% |
| Fund Existence | 32 years | 24 years | - |
| Gain YTD | -4.750 | 9.965 | -48% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 163M | 112B | 0% |
| Annual Yield % from dividends | 2.60 | 1.43 | 182% |
| Returns for 1 year | -6.00 | 8.33 | -72% |
| Returns for 3 years | 3.88 | 30.01 | 13% |
| Returns for 5 years | 9.38 | 48.36 | 19% |
| Returns for 10 years | -3.00 | 99.29 | -3% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LAFTX | 20.45 | 0.07 | +0.34% |
| Lord Abbett Affiliated R5 | |||
| AEMMX | 14.21 | 0.03 | +0.21% |
| American Century Emerging Markets A | |||
| NAINX | 9.77 | 0.02 | +0.21% |
| Virtus Tactical Allocation A | |||
| BKDEX | 10.80 | 0.01 | +0.09% |
| BlackRock Defensive Advantage EM K | |||
| BIPSX | 36.16 | N/A | N/A |
| ProFunds Biotechnology UltraSector Svc | |||